REFERENCES
- Capel MM, Colbridge MG, Henry JA. Overdose Profiles of New Antipsychotic Agents. Int J Neuropsychopharmacol 2000; 3: 51–54
- Prescribing Information for Zyprexa (olanzapine). Eli Lilly and Company, Indianapolis 2003
- Watson WA, Litovitz TL, Rodgers GC, Jr., Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME. 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21: 353–421, [CROSSREF]
- Fogel J, Diaz JE. Olanzapine Overdose. Ann Emerg Med 1998; 32: 275–6
- Gardner DM, Milliken J, Dursun SM. Olanzapine Overdose. Am J Psychiatry. 1999; 156: 1118–1119
- O’Malley GF, Seifert S, Heard K, Daly F, Dart RC. Olanzapine Overdose Mimicking Opioid Intoxication. Ann Emerg Med 1999; 34: 279–281
- Cohen LG, Fatalo A, Thompson BT, Bergeron GD, Flood JG, Roupolo PR. Olanzapine Overdose with Serum Concentrations. Ann Emerg Med 1999; 34: 275–278, [CROSSREF]
- Yip L, Dart RC, Graham K. Olanzapine Toxicity in a Toddler. Pediatrics 1998; 102: 1494, [CROSSREF]
- Bond GR, Thompson JD. Olanzapine Pediatric Overdose. Ann Emerg Med 1999; 34: 292–293
- Bonin MM, Burkhart KK. Olanzapine Overdose in a 1-year-old Male. Pediatr Emerg Care 1999; 15: 266–267
- Catalano G, Cooper DS, Catalano MC, Butera AS. Olanzapine Overdose in an 18-month-old Child. J Child Adolesc Psychopharmacol 1999; 9: 267–271
- Elian AA. Fatal Overdose of Olanzapine. Forensic Sci Int 1998; 91: 231–235, [CROSSREF]
- Gerber JE, Cawthon B. Overdose and Death with Olanzapine. Am J Forensic Med Pathol 2000; 21: 249–251, [CROSSREF]
- Merrick TC, Felo JA, Jenkins AJ. Tissue Distribution of Olanzapine in a Postmortem Case. Am J Forensic Med Pathol 2001; 22: 270–274, [CROSSREF]
- Chengappa KNR, Pollock BG, Parpally H, Levine J, Kirshner MA, Brar JS, Zoretizh RA. Anticholinergic Differences Among Patients Receiving Standard Clinical Doses of Olanzapine or Clozapine. J Clin Psychopharm 2000; 20: 311–316, [CROSSREF]
- Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD. Breier for the HGEU Study Group. Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients with Alzheimer Disease in Nursing Care Facilities. Arch Gen Psychiatry 2000; 57: 968–976, [CROSSREF]
- Hoffman DC, Donovan H. Catalepsy as a Rodent Model for Detecting Antipsychotic Drugs with Extrapyramidal Side Effect Liability. Psychopharmacology 1995; 120: 128–133, [CROSSREF]
- Chambers RA, Caracansi A, Weiss G. Olanzapine Overdose Cause of Acute Extrapyramidal Symptoms. Am J Psychiatry 1998; 155: 1626
- Robertson MD, McMullin MM. Olanzapine Concentrations in Clinical Serum and Postmortem Blood Specimens. J Forensic Sci 2000; 45: 418–421
- Bosch RF, Baumbach A, Bitzer M, Erley CM. Intoxication with Olanzapine. Am J Psychiatry 2000; 157: 304–305, [CROSSREF]
- Ferraro KK, Burkhart KK, Donovan JW, O’Donnell SJ. A Retrospective Review of Physostigmine in Olanzapine Overdose. J Toxicol Clin Toxicol 2001; 39: 474